TNGX
Tango Therapeutics Inc.
Company Overview
| Mkt Cap | $866.72M | Price | $8.11 |
| Volume | 2.59M | Change | +1.76% |
| P/E Ratio | -6.7 | Open | $7.97 |
| Revenue | $42.1M | Prev Close | $7.97 |
| Net Income | $-130.3M | 52W Range | $1.03 - $9.70 |
| Div Yield | N/A | Target | $11.63 |
| Overall | 55 | Value | 60 |
| Quality | -- | Technical | 50 |
No chart data available
Stock Overview
Updated DailyTango Therapeutics Inc. (TNGX) is a leading Professional, Scientific, and Technical Services company in the Research and Development in Biotechnology industry, currently trading at $8.11 with a market capitalization of $866.72 million. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows TNGX with a volume of 2.59 million shares. The stock opened down 0.00% from yesterday's close of $7.97. Current analyst estimates project earnings of $-1.05 per share for this year, with next year targeting $-1.46.
TNGX demonstrates neutral technical outlook based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including NWBO, NYMX, OHCS, OMIC.
Key investment considerations for TNGX include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 43.4%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 04:13 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TNGX | $8.11 | +1.8% | 2.59M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |